ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis-Reference-Cited by-同舟云学术

ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis

Published:2021-09-06 Issue:4 Volume:58 Page:546-552
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound Obstet Gynecol

Author:

Shen L.¹²^ORCID,Martinez‐Portilla R. J.³⁴⁵^ORCID,Rolnik D. L.⁶^ORCID,Poon L. C.¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynaecology, Prince of Wales Hospital The Chinese University of Hong Kong Shatin, Hong Kong SAR China

2. Department of Obstetrics and Gynecology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

3. Clinical Research Division, National Institute of Perinatology “Isidro Espinosa de lo Reyes” Mexico City Mexico

4. Iberoamerican Research Network in Obstetrics Gynecology and Translational Medicine Mexico City Mexico

5. Fetal Medicine Research Center, BCNatal, Barcelona Center for Maternal–Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Institut Clínic de Ginecologia, Obstetricia i Neonatologia Universitat de Barcelona Barcelona Spain

6. Department of Obstetrics and Gynaecology Monash University Melbourne VIC Australia

Funder

Fetal Medicine Foundation

FP7 Health

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/uog.23668

Reference22 articles.

1. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia